GB8502889D0 - Co-dergocrine compositions - Google Patents

Co-dergocrine compositions

Info

Publication number
GB8502889D0
GB8502889D0 GB858502889A GB8502889A GB8502889D0 GB 8502889 D0 GB8502889 D0 GB 8502889D0 GB 858502889 A GB858502889 A GB 858502889A GB 8502889 A GB8502889 A GB 8502889A GB 8502889 D0 GB8502889 D0 GB 8502889D0
Authority
GB
United Kingdom
Prior art keywords
dergocrine
compositions
dergocrine compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB858502889A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Priority to GB858502889A priority Critical patent/GB8502889D0/en
Publication of GB8502889D0 publication Critical patent/GB8502889D0/en
Priority to HU86361A priority patent/HU195729B/en
Priority to NL8600161A priority patent/NL8600161A/en
Priority to CH296/86A priority patent/CH667592A5/en
Priority to DE19863602577 priority patent/DE3602577A1/en
Priority to FR868601477A priority patent/FR2576787B1/en
Priority to AU52942/86A priority patent/AU597570B2/en
Priority to GR860310A priority patent/GR860310B/en
Priority to IE29186A priority patent/IE59293B1/en
Priority to PT81954A priority patent/PT81954B/en
Priority to BE1/011431A priority patent/BE904152A/en
Priority to KR1019860000698A priority patent/KR920010388B1/en
Priority to NZ215020A priority patent/NZ215020A/en
Priority to GB08602602A priority patent/GB2170407B/en
Priority to CA000501011A priority patent/CA1263087A/en
Priority to DK052086A priority patent/DK167138B1/en
Priority to ES551635A priority patent/ES8800040A1/en
Priority to LU86289A priority patent/LU86289A1/en
Priority to AT0026286A priority patent/AT388101B/en
Priority to JP61023666A priority patent/JPS61183225A/en
Priority to PH33379A priority patent/PH23384A/en
Priority to SE8600496A priority patent/SE8600496L/en
Priority to IT47620/86A priority patent/IT1191255B/en
Priority to ZA86848A priority patent/ZA86848B/en
Priority to US07/542,457 priority patent/US5069911A/en
Priority to SG561/91A priority patent/SG56191G/en
Priority to HK571/91A priority patent/HK57191A/en
Priority to CY1604A priority patent/CY1604A/en
Priority to MX9203583A priority patent/MX9203583A/en
Pending legal-status Critical Current

Links

GB858502889A 1985-02-05 1985-02-05 Co-dergocrine compositions Pending GB8502889D0 (en)

Priority Applications (29)

Application Number Priority Date Filing Date Title
GB858502889A GB8502889D0 (en) 1985-02-05 1985-02-05 Co-dergocrine compositions
HU86361A HU195729B (en) 1985-02-05 1986-01-24 Process for producing pharmaceutical compositions containing 9,10-dihydro-ergot-alkaloides
NL8600161A NL8600161A (en) 1985-02-05 1986-01-24 PHARMACEUTICAL PREPARATIONS CONTAINING 9,10-DIHYDROGOTALKALOIDS.
CH296/86A CH667592A5 (en) 1985-02-05 1986-01-27 PHARMACEUTICAL COMPOSITIONS CONTAINING 9,10-DIHYDROGENATED ERGOTAL CALOIDS.
DE19863602577 DE3602577A1 (en) 1985-02-05 1986-01-29 PHARMACEUTICAL COMPOSITIONS CONTAINING 9,10-DIHYDROGENATED ERGOTAL CALOIDS
FR868601477A FR2576787B1 (en) 1985-02-05 1986-01-31 SUSTAINED RELEASE FORMULATION CONTAINING Rye ergot alkaloids
DK052086A DK167138B1 (en) 1985-02-05 1986-02-03 PHARMACEUTICAL PREPARATIONS CONTAINING ERGOTAL KALOIDS
CA000501011A CA1263087A (en) 1985-02-05 1986-02-03 Pharmaceutical 9,10-dihydrogenated ergot alkaloid containing compositions
GR860310A GR860310B (en) 1985-02-05 1986-02-03 Pharmaceutical 9,10-dihydro ergot alkaloid containing compositions
IE29186A IE59293B1 (en) 1985-02-05 1986-02-03 Pharmaceutical 9,10-dihydro ergot alkaloid containing compositions
PT81954A PT81954B (en) 1985-02-05 1986-02-03 METHOD FOR PREPARING PHARMACEUTICAL COMPOSITIONS CONTAINING 9,10-DIHYDRO-ALCALOIDS FROM RYE CRUSHING
BE1/011431A BE904152A (en) 1985-02-05 1986-02-03 SUSTAINED RELEASE FORMULATION CONTAINING Rye ergot alkaloids.
KR1019860000698A KR920010388B1 (en) 1985-02-05 1986-02-03 Process for the preparation of pharmaceutical compositions containing 9,10-dihydro alkaloids of ergot
NZ215020A NZ215020A (en) 1985-02-05 1986-02-03 Controlled release formulations containing ergot alkaloids
GB08602602A GB2170407B (en) 1985-02-05 1986-02-03 Pharmaceutical 9,10-dihydro ergot alkaloid containing compositions
AU52942/86A AU597570B2 (en) 1985-02-05 1986-02-03 Pharmaceutical 9,10-dehydrogenated ergot alkaloid containing compositions
LU86289A LU86289A1 (en) 1985-02-05 1986-02-04 SUSTAINED RELEASE FORMULATION CONTAINING Rye ergot alkaloids
SE8600496A SE8600496L (en) 1985-02-05 1986-02-04 PHARMACEUTICAL COMPOSITIONS CONTAINING 9,10-DIHYDROERGOTAL KALOIDS
ES551635A ES8800040A1 (en) 1985-02-05 1986-02-04 Pharmaceutical 9,10-dihydrogenated ergot alkaloid containing compositions
AT0026286A AT388101B (en) 1985-02-05 1986-02-04 Process for the production of a pharmaceutical composition for oral administration with controlled release of active ingredient
JP61023666A JPS61183225A (en) 1985-02-05 1986-02-04 Medicinal composition containing 9,10- dihydroergot alkaloid
PH33379A PH23384A (en) 1985-02-05 1986-02-04 Pharmaceutical 9,10-dihydrogenated ergot alkaloid containing compositions and method use thereof
IT47620/86A IT1191255B (en) 1985-02-05 1986-02-05 PHARMACEUTICAL COMPOSITION OF ALCALOIDS BASED ON THE RUNNING RING 9.10-DIHYDROGENATES
ZA86848A ZA86848B (en) 1985-02-05 1986-02-05 Pharmaceutical 9,-10-dihydrogenated ergot alkaloid containing compositions
US07/542,457 US5069911A (en) 1985-02-05 1990-06-22 Pharmaceutical 9,10-dihydrogenated ergot alkaloid containing compositions
SG561/91A SG56191G (en) 1985-02-05 1991-07-16 Pharmaceutical 9,10-dihydro ergot alkaloid containing compositions
HK571/91A HK57191A (en) 1985-02-05 1991-07-25 Pharmaceutical 9,10-dihydro ergot alkaloid containing compositions
CY1604A CY1604A (en) 1985-02-05 1992-04-03 Pharmaceutical 9,10-dihydro ergot alkaloid containing compositions
MX9203583A MX9203583A (en) 1985-02-05 1992-06-26 PHARMACEUTICAL COMPOSITION OF PROLONGED RELEASE BASED ON 9,10-DIHYDRO-ALCALOIDS.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB858502889A GB8502889D0 (en) 1985-02-05 1985-02-05 Co-dergocrine compositions

Publications (1)

Publication Number Publication Date
GB8502889D0 true GB8502889D0 (en) 1985-03-06

Family

ID=10573971

Family Applications (1)

Application Number Title Priority Date Filing Date
GB858502889A Pending GB8502889D0 (en) 1985-02-05 1985-02-05 Co-dergocrine compositions

Country Status (2)

Country Link
GB (1) GB8502889D0 (en)
ZA (1) ZA86848B (en)

Also Published As

Publication number Publication date
ZA86848B (en) 1987-09-30

Similar Documents

Publication Publication Date Title
IL78934A (en) Alfuzosine compositions
GB8514052D0 (en) Compositions
MW5186A1 (en) Compositions
GB8508717D0 (en) Composition
GB8500862D0 (en) Composition
GB8509409D0 (en) Compositions
GB8524508D0 (en) Composition
GR860123B (en) Compositions
GB8508404D0 (en) Therapeutic compositions
EP0192630A3 (en) Aminomethylenephosphonate compositions
GB8513550D0 (en) Compositions
GB8529409D0 (en) Aminomethylenephosphonate compositions
GB8514418D0 (en) Aminobenzylamine composition
GB8603048D0 (en) Lymphokine-containing compositions
GB8501400D0 (en) Compositions
GB8520289D0 (en) Compositions
GB8502889D0 (en) Co-dergocrine compositions
EG17458A (en) Fungicial compositions
GB8528980D0 (en) Compositions
GB8526499D0 (en) Compositions
GB8518081D0 (en) Compositions
GB8518579D0 (en) Compositions
GB8518580D0 (en) Compositions
GB8518581D0 (en) Compositions
GB8504463D0 (en) Compositions